newsfilter
← Latest News
ACCESS Newswire·

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025

Reports Net Revenues of $170.5 Million for the Three Months Ended March 31, 2025 RANCHO CUCAMONGA, CA / ACCESS Newswire / May 7, 2025 / Amphastar Pharmaceuticals, Inc. ("Amphastar" or the